Our Services

Comprehensive Healthcare Solutions Tailored for Your company

doctor-consulting-with-patient.jpg

Consultancy Services

Learn about our personalized consultancy services

Product Commercialization

  • You start with the model and decide this agent has a chance for success in humans
  • How do you know if your product will succeed beyond animal models and Artificial Intelligence? 
  • In conversation with the thought leaders, it certainly looks great and can have its place in the market post clinical trials.
  • Questions to start with: the product mechanism of action? 
  • In terms of mechanism, does it act on the known receptor sites, such as sodium or potassium?
  • Will those actually limit the use of product such as, with potassium?
  • The delivery system of the product? 
  • is it delivered orally, intrathecally? Or, as an attached device?
  • Broad use or rare disease? (This determines the potential size of the sales force)
  • Device or drug (including gene therapy)?
  • What are the efficacy rates in the marketplace? If there is only a ten percent seizure freedom difference between your gene therapy at $100K versus current products, is it worth the commercialization?  
  • Anticipated pricing strategy? Rare disease over $100K? Broad use? $2K per month? In the US, what about Europe and their negotiated hardline pricing? 
  • Food & Drug Administration? 
  • Selection of the “right” Clinical Research Organization to conduct the studies in a cost effective, timely and efficient manner 
  • Study site selection and key opinion leader involvement
  • Commercialize or license to another company? There are advantages and disadvantages for both

Leadership

  • Targeted Selection for the commercial team, what matters most for each of the positions? Is the resume enough? Hiring friends for roles? How do you know if people are the right fit for rare disease?  
  • Incentive Compensation plans. For instance, rare disease IC plan must include LTI
  • Productivity means of success for the commercial team 
  • First line leader impact assessment
  • Mid-level to executive level leadership, cost versus benefit
  • Sales Account Manager impact and assessment

Sales and Marketing Effectiveness

  • Marketing Plans aligned with medical and the sales team
  • Commercial team pain points
  • Situational Leadership
  • Performance Management
  • People development plan 
  • Business Plans aligned with strategy and not just tactics 
  • Sales people trained to influence and persuade
  • Clinical reprints available for the commercial team
  • Insurance and market access plans acceptance in balance without giving away revenue
  • Limited Distribution Network for rare disease to ensure of timely insurance approval and delivery to patients
  • Solutions offered to these and other questions in rare disease commercial sales 
  • Advocacy partnership 

Culture

  • Corporate culture – goal versus reality. 
  • Ethical and uncompromised
  • Employee retention: Do employees really want to stay? Or, is there nothing better in the market?
  • Listening to feedback across the organization 
  • Commercial team pain points
  • Employee retention: Do employees really want to stay? Or, is there nothing better in the market?
  • Silos, protect your job, versus connectivity in culture.